TERT and pulmonary fibrosis: Importantly, half of the mice receiving TERT-expressing AAV9 showed undetectable lung fibrosis at 8 weeks post systemic viral administration, whereas all mice treated with an empty AAV9 vector showed severe fibrotic lesions.